Standard InChI: InChI=1S/C48H92O18S.Na/c1-4-6-8-10-12-14-16-18-20-22-24-26-28-34(29-27-25-23-21-19-17-15-13-11-9-7-5-2)32-60-46-42(56)45(65-47-40(54)39(53)37(51)33(3)61-47)43(36(31-50)63-46)64-48-41(55)44(66-67(57,58)59)38(52)35(30-49)62-48;/h33-56H,4-32H2,1-3H3,(H,57,58,59);/q;+1/p-1/t33-,35+,36+,37+,38-,39+,40-,41+,42+,43+,44-,45+,46+,47-,48-;/m0./s1
1.Hiramatsu Y, Tsukida T, Nakai Y, Inoue Y, Kondo H.. (2000) Study on selectin blocker. 8. Lead discovery of a non-sugar antagonist using a 3D-pharmacophore model., 43 (8):[PMID:10780903][10.1021/jm990342j]
2.Hiramatsu Y, Moriyama H, Kiyoi T, Tsukida T, Inoue Y, Kondo H.. (1998) Studies on selectin blockers. 6. Discovery of homologous fucose sugar unit necessary for E-selectin binding., 41 (13):[PMID:9632363][10.1021/jm9707481]
3.Tsukida T, Hiramatsu Y, Tsujishita H, Kiyoi T, Yoshida M, Kurokawa K, Moriyama H, Ohmoto H, Wada Y, Saito T, Kondo H.. (1997) Studies on selection blockers. 5. Design, synthesis, and biological profile of sialyl Lewis x mimetics based on modified serine-glutamic acid dipeptides., 40 (22):[PMID:9357520][10.1021/jm970262k]
4.Tsujishita H, Hiramatsu Y, Kondo N, Ohmoto H, Kondo H, Kiso M, Hasegawa A.. (1997) Selectin-ligand interactions revealed by molecular dynamics simulation in solution., 40 (3):[PMID:9022803][10.1021/jm9606103]
5.Tsukida T, Moriyama H, Kurokawa K, Achiha T, Inoue Y, Kondo H.. (1998) Studies on selectin blockers. 7. Structure-activity relationships of sialyl Lewis X mimetics based on modified Ser-Glu dipeptides., 41 (22):[PMID:9784103][10.1021/jm980267x]
6.Govindarajan M.. (2018) Amphiphilic glycoconjugates as potential anti-cancer chemotherapeutics., 143 [PMID:29126728][10.1016/j.ejmech.2017.10.015]